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TO THE EDITOR
The versatile cytolinker plectin (gene:
PLEC1) (inter)connects intermediate fi-
laments (IFs), actin, and microtubules in
various tissues (Wiche et al., 1983;
Wiche, 1998). At its C-terminus, plectin
anchors IFs at organelles and cell
junctions, such as hemidesmosomes
and desmosomes in skin, costameres
and Z-discs in muscle, and additionally
intercalated discs (IDs) in myocardium
(Wiche, 1998; Sonnenberg and Liem,
2007; Konieczny and Wiche, 2008).
The N-terminus of plectin harbors a
highly conserved actin-binding domain
(ABD), followed by nine spectrin re-
peats (SRs) (Figure 1c) (Sonnenberg
et al., 2007), and binds to actin, b4
integrin, type XVII collagen (BP180),
the nuclear envelope protein nesprin-
3a, and sarcolemmal proteins in muscle
(Andra et al., 1998; Rezniczek et al.,
1998, 2007; Geerts et al., 1999; Koster
et al., 2003; Wilhelmsen et al., 2005;
Hijikata et al., 2008). Plectin knockout
mice died during the first few postnatal
days, showing skin fragility, muscular
pathology, and cardiomyopathy (Andra
et al., 1997). In humans, recessive PLEC1
mutations are associated with skin
fragility (epidermolysis bullosa simplex
(EBS)) in association with muscular
dystrophy (EBS-MD) or pyloric atresia
(McLean et al., 1996; Nakamura
et al., 2005).
Schroder et al. (2002) have de-
scribed a 25-year-old woman with a
homozygous frameshift mutation in the
plectin C-terminus that caused a pre-
mature termination codon (PTC) and
marked plectin deficiency. In addition
to her profound early-onset (age 11
years) muscle weakness, brain abnorm-
alities, bilateral cataracts, and an
arteriovenous malformation, she was
noted to have asymptomatic left
ventricular hypertrophy. No other
PLEC1 mutations associated with
cardiac pathology have been described
and no studies have shown plectin
in human myocardium yet. In this study,
we report on a patient with EBS-
MD with compound heterozygous
PLEC1 mutations, who developed an
adult-onset biventricular dilated cardio-
myopathy (DCM). The expression of
plectin and its binding partners in the
skin, skeletal muscle, and myocardium
was analyzed using immunofluorescence
microscopy.
The proband, a 40-year-old man,
suffered from lifelong skin blistering
with an intraepidermal split, and nail
dystrophy (Supplementary Figure S1a–c
and e–h online). In his twenties, a
progressive weakness of shoulder girdle
and upper extremity musculature be-
came apparent and was confirmed by
histopathological findings in a muscle
biopsy (Supplementary Figure S1j
online). Earlier, he enjoyed sportive
activities and also worked as a me-
chanic, which is, at present, no longer
possible. At the age of 30 years,
preoperative screening for a large lipo-
ma excision revealed an asymptomatic
left ventricular DCM. Electrocardio-
graphic (ECG) studies showed left axis
deviation with aspecific intraventricular
conduction delay (QRS duration
116ms), sinus bradycardia, frequent
ventricular ectopic beats, including
bouts of nonsustained ventricular
tachycardia. Echocardiography and
cardiovascular magnetic resonance
imaging (MRI) initially revealed left
ventricular dilatation, which later pro-
gressed to right ventricle involvement.
A biopsy from interventricular cardiac
septum showed fibrosis and atrophic
fibers. His sister, who is 9 years young-
er, showed similar skin features (Sup-
plementary Figure S1d online).
However, she clearly refused medical
care, follow-up, and information re-
garding further mutation analysis results
when she realized that the
late-onset muscular disease of her
brother was related to the skin disease,
as she did not want to be confronted
with her possible future. His non-
consanguineous parents and another
sister were unaffected, and family history
with regard to cardiovascular diseases
was negative (for pedigree, see Supple-
mentary Figure S1i online). Informed
consent was obtained from the patient.
The medical ethical committee of the
University Medical Center Groningen,
the Netherlands, gave approval for studies
on human material initially obtained
for diagnostic means. Studies were per-
formed according to the Declaration
of Helsinki Principles. DNA was ob-
tained from all members of the
family. Amplification and direct se-
quencing of PLEC1 coding regions were
performed (primers and conditions
available on request), which revealed
compound heterozygosity for a not
previously described missense mutation
(c.1019G4A, p.Arg323Gln) and
a nonsense mutation (c.4891G4T,
p.Glu1614X) in the proband and
the affected sister (Figure 1a and b).
The father was heterozygous
for p.Arg323Gln and the mother for
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p.Glu1614X. The unaffected sister
did not carry either one of the
mutations. The highly conserved
p.Arg323 residue (for conservation
see Supplementary Figure S2 online)
resides in the a-helical SR1 in plectin’s
N-terminus (Figure 1c). Mutation
p.Arg323Gln was excluded in 100
unrelated control DNA samples
and was not found in the single-
nucleotide polymorphism database of
the National Center for Biotechnology
Information (Sherry et al., 2001).
Western blotting of proband’s keratino-
cyte extracts and RNA analysis
indicated loss of full-length plectin
expression from the p.Glu1614X-con-
taining allele. The analysis of the
proband’s DNA for mutations in
genes KRT5 (keratin 5), KRT14
(keratin 14), DES (desmin), DMD
(dystrophin), and LMNA (lamin A/C)
was negative.
Immunofluorescence microscopy was
performed on the skin (Figure 2a),
skeletal muscle (Figure 2b), and myocar-
dium (Figure 2c) of the proband using
mAbs against plectin (hemidesmosome
(HD)121, 10F6, 5B3, 6C6), BP180
(1D1), BP230 (R815), integrin b4
(58XB4), desmin (CloneD33; Biogenex,
San Ramon, CA, USA), desmoplakin
(Dp2.17; Progen, Heidelberg, Germany),
and plakoglobin (PG5.1; Progen).
In all tissues, plectin staining was slightly
diminished, whereas plectin-binding
partners showed diminished and/or
aberrant staining patterns. In the
skin, BP180 and BP230 were diminished
(Figure 2a). Integrin b4 stainings
were normal (data not shown). Skeletal
muscle of the proband showed
desmin aggregations (Figure 2b). In
myocardium stainings for desmin,
desmoplakin and plakoglobin (data not
shown) showed retraction to a more
cytoplasmic position (Figure 2c).
Desmin cross-striated Z-disc staining
was disrupted. Anti-plectin mAbs
10F6, 5B3, and 6C6 revealed slightly
different expression patterns on control
human myocardium, indicating the
presence of different plectin isoforms
with a structure-specific expression
(Supplementary Figure S3b online).
Plectin staining at IDs and Z-discs
was perturbed in the proband with
cytoplasmic aggregations. Double
stainings of human control myocardium
showed close alignment of plectin
and desmin at IDs and Z-discs, whereas
in myocardium of the proband,
plectin–desmin colocalization at IDs
and Z-discs was lost (Supplementary
Figure S3a online).
The patient in this study is the
second case of cardiomyopathy that
could be attributed to PLEC1 mutations
in humans, although involvement of
additional (modifier) genes in develop-
ment cannot be completely excluded.
Cardiac disease in other cases with
PLEC1 mutations might have been
missed because the reported patient
was young and/or because the cardiac
disease is initially asymptomatic, mild
and slowly progressive (activity depen-
dent, and activity is impaired in patients
with early-onset MD). Patients with
severe MD often die because of
respiratory problems, but perhaps
(unnoticed) cardiomyopathy may have
worsened the course. Mutation
p.Glu1614X in homozygous state
caused EBS-MD, and no additional data
were given about the patient (Pfendner
et al., 2005). Concerning the present
case, we hypothesize that because of
the missense mutation, the structure of
the plectin amino-terminus is altered
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Figure 1. Compound heterozygous PLEC1 mutations in epidermolysis bullosa simplex-muscular dystrophy (EBS-MD) with dilated cardiomyopathy (DCM).
DNA mutation analysis revealed compound heterozygous PLEC1 mutations in the proband and his affected sister. (a) On the paternal allele, a heterozygous
c.1019G4A substitution was found, changing a highly conserved arginine (CGA) into a glutamine (CAA) at residue 323 in the plectin protein, Arg323Gln
(GenBank NM_000445.2). (b) On the maternal allele, a heterozygous c.4891G4T substitution was detected changing a glutamic acid (Glu) into a premature
termination codon (X) at residue 1614, Glu1614X (GenBank NM_000445.2). (c) Schematic representation of the plectin protein, with the mutations found in
this study depicted in red boxes. The nonsense mutation Glu1614X is located in the rod domain, whereas the missense mutation resides in the first a-helical
spectrin repeat segment of plectin, adjacent to the actin-binding domain (ABD).
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and therefore binding to actin and/or
costameric proteins in cardiomyocytes
is attenuated. Consequently, proper
localization of plectin at Z-discs, IDs,
and costameres is lost, along with
anchorage of the desmin IF system.
Similarly, in skin, the plectin–inte-
grin–b4 interaction, and the subsequent
attraction of BP180 and BP230 in
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Figure 2. Aberrant staining patterns of plectin and its binding partners in the skin, skeletal muscle, and myocardium of the proband. (a) Immunofluorescence
microscopy of nonlesional skin of the proband (right panels) showed slightly diminished plectin (5B3) staining along the basement membrane zone (BMZ)
and absent staining of intercellular substance (arrow in control) in the basal layers. Stainings for BP180 (1D1) and BP230 (R815), along BMZ, were reduced.
(b) Subsarcolemmal and cytoplasmic desmin aggregations (arrows) are seen in a skeletal muscle biopsy of the proband (right panels). As described by McMillan
et al. (2007), in cross-sections of normal skeletal muscle, plectin 10F6 staining shows a checkerboard-like distribution with cytoplasmic and sarcolemmal
(closed arrowheads) staining of type II fibers and only sarcolemmal staining in type I fibers, contrary to the hemidesmosome (HD)121 staining as described
by Schroder et al. (1997). In the proband, 10F6 staining was preserved. Type II fibers were small and few in number (arrow). Note the cytoplasmatic nuclei,
the variable diameter of muscle fibers, and the widened interfiber spaces as signs of muscular dystrophy. (c) Immunofluorescence staining for desmoplakin
on myocardial tissue of the proband (right panels) showed widened intercalated discs (IDs) (arrow) with a more cytoplasmatic position of desmoplakin.
Desmin staining at IDs (arrows) was retracted to a more cytoplasmic position and Z-disc staining (open arrowhead) was disrupted. In proband myocardium,
plectin (10F6) staining showed depletion at IDs and abnormal aggregates (closed arrowheads). Scale bar¼50 mm.
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hemidesmosomes, is impaired, together
with the anchorage of keratins. Our
findings are in line with the observa-
tions in plectin knockout mice and
desmosome-defective human cardio-
myopathy. In plectin knockout mice,
the cytoarchitecture of skin, skeletal
muscle, and myocardium is abnormal,
showing loss of the cross-striated des-
min pattern and focal disorganization of
the contractile unit in heart and skeletal
muscle, which is similar to the micro-
scopic findings in our patient (Andra
et al., 1997). Muscle-specific plectin
knockout mice showed exercise-depen-
dant skeletal and cardiac muscle
pathology (Konieczny et al., 2008).
In vitro studies indicated colocalization
of plectin with desmoplakin at desmo-
somes (Eger et al., 1997). Mutations
in other myocardial-expressed desmo-
somal proteins have been associated
with DCM and arrhythmogenic
right ventricle cardiomyopathy (ARVC;
van Tintelen et al., 2007). Further-
more, mutations in several costameric
binding partners of plectin and desmin
cause DCM (Elliott et al., 2008).
Considering these observations and
the findings in the present study,
we believe cardiological screening of
patients with plectin mutations is
warranted and (although yet specula-
tion) vice versa; PLEC1 is a candidate
gene for involvement in idiopathic
ARVC and DCM.
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